newsfilter
← Latest News
GlobeNewswire·

KemPharm to Participate in BIO Partnering @ JPM During "J.P. Morgan Week 2022"

CELEBRATION, Fla., Jan. 06, 2022 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NASDAQ:KMPH), a specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs, announced today the company is participating in BIO Partnering @ JP